Developer docs
API playgroundTry for free, no card

Search company profiles

Axsendo Clinical Research

Full company profile

uuid00k3ptp

Namestring
Axsendo Clinical Research
Legal namestring
Axsendo Clinical Research, LLC
Company typeenum
Private
Founded yearint
2024
Descriptiontext

Axsendo Clinical Research is a woman-owned clinical research site platform operating a national network of embedded Phase I–IV research sites across the western and southwestern United States. The company deploys research capabilities inside or alongside physician practices rather than as standalone facilities, giving it a co-located model that uses physician partners as the primary patient-enrollment channel. As of the input period the network spans 9+ locations including Houston, Phoenix, Portland, San Diego, Las Vegas, Albuquerque, Tucson, Denver, and a Sacramento site listed as coming soon.

The platform layers centralized operational features over the embedded site model, including a 48-hour contract and budget response, a single point of contact across studies, simplified site assessments, and what the company describes as accurate enrollment forecasting. Therapeutic breadth is positioned as a differentiator, with active or planned coverage across Pulmonary, Cardiology, Vaccine and Infectious Disease, Endocrinology, Orthopedics, Ophthalmology, Gastroenterology, and Nephrology. Leadership combines a founder-CEO with a National Medical Advisor and Principal Investigator (Dr. Frank LoVecchio, joined August 2024 in Phoenix), and the company cites more than 100 years of combined clinical research experience across its team.

The business model is professional services: revenue is generated through study contracts with pharmaceutical sponsors and CROs, per-patient fees tied to enrollment, and fixed site costs. Go-to-market is structured around three channels — enterprise sales to pharma sponsors and CROs, direct-to-consumer patient recruitment, and a physician partnership program that underpins site embedding and referrals. The company is structured as a US LLC, was founded in 2024, reports 11–50 employees, and has not disclosed outside funding.

Short descriptiontext

Axsendo Clinical Research is a woman-owned, multi-site clinical research platform operating 9+ embedded Phase I–IV sites across the western US, serving pharmaceutical sponsors, CROs, and patients through physician-led enrollment partnerships.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPhoenix, United States
HQ citystring
Phoenix
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices9 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial site network, contract research organization, Phase I-IV clinical trials, patient recruitment services, principal investigator partnerships
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Other Scientific and Technical Consulting Services541690
SIC code2 codes
  • Services-Health Services8000
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Contract Research Organization (CRO) - Clinical Trial Site Network
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Clinical Research Services for Sponsors and CROs
TypeProfessional Services
Description

Provides Phase I-IV clinical trial site services to pharmaceutical sponsors and Contract Research Organizations. Revenue generated through study contracts, per-patient fees, and fixed-site costs.

axsendoclinicalresearch.com
2Patient Recruitment and Retention Services
TypeProfessional Services
Description

Identifies and recruits qualified patients through multiple engagement channels for clinical trials, supporting sponsor enrollment goals.

axsendoclinicalresearch.com
3Participant Compensation
TypeProfessional Services
Description

Clinical trial participants may receive compensation for time and travel (e.g., up to $1,500 for low back pain study), which represents a cost offset rather than direct revenue.

axsendoclinicalresearch.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D
Pricing details2 tiers
1Custom clinical trial site services pricing
ModelOthersBilling cadenceMulti-year contract
Notes

Contract-based pricing for pharmaceutical sponsors and CROs for clinical trial site services including patient recruitment, site operations, and regulatory compliance. Not publicly disclosed.

axsendoclinicalresearch.com
2Participant compensation for clinical trial participation
ModelOthersBilling cadencePay-as-you-go
Notes

Compensation varies by study. Example: Low back pain study offers up to $1,500 for time and travel. COPD and asthma studies may offer payment for participation.

axsendoclinicalresearch.com
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

Axsendo Clinical Research operates a national site network providing Phase I-IV clinical trial capabilities that integrate research directly into everyday medical care through an embedded site model partnering with local physicians. The company delivers clinical trial site services to pharmaceutical sponsors and CROs across therapeutic areas including pulmonary, cardiology, vaccine and infectious disease, endocrinology, orthopedics, ophthalmology, gastroenterology, and nephrology, while concurrently recruiting patient participants for studies at its 9+ physical research locations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Lightning-fast 48-hour response to contract and budget inquiries
+3 more records
Product overview1 text field

Axsendo Clinical Research operates a unified national site network for clinical trials, offering embedded research services that integrate clinical trials directly into everyday medical care. The platform provides Phase I-IV clinical trial capabilities through multiple locations (Houston, Phoenix, Portland, Sacramento, San Diego, Las Vegas, Albuquerque, Tucson, Denver), partnering with trusted local physicians to expand patient access to innovative therapies. The offering combines experienced research staff, centralized operations, regulatory compliance support, and patient recruitment services across therapeutic focus areas including pulmonary, cardiology, vaccine and infectious disease, endocrinology, orthopedics, ophthalmology, gastroenterology, and nephrology.

Product and service3 records
1Clinical Research Site Network Services
CategoryClinical Trial Site Services
Description

National site network providing Phase I-IV clinical trial capabilities that connects physician investigators with diverse patient populations to conduct pharmaceutical and medical device studies across multiple therapeutic areas.

2Clinical Trial Enrollment Services
CategoryPatient Recruitment Services
Description

Patient recruitment and enrollment services that identify and connect eligible participants with appropriate clinical studies across multiple therapeutic areas, supporting sponsor enrollment goals.

3Physician Partnership Program
CategoryPhysician Partnership Program
Description

Partnership program offering physicians turn-key research capabilities including experienced clinical research teams, trial pipeline development, patient recruitment, and operational support to integrate clinical research into physician practices without administrative burden.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Axsendo Clinical Research

Contract Research Organization (CRO) - Clinical Trial Site Networkaxsendoclinicalresearch.com

Axsendo Clinical Research is a woman-owned, multi-site clinical research platform operating 9+ embedded Phase I–IV sites across the western US, serving pharmaceutical sponsors, CROs, and patients through physician-led enrollment partnerships.

What Axsendo Clinical Research does

Axsendo Clinical Research is a woman-owned clinical research site platform operating a national network of embedded Phase I–IV research sites across the western and southwestern United States. The company deploys research capabilities inside or alongside physician practices rather than as standalone facilities, giving it a co-located model that uses physician partners as the primary patient-enrollment channel. As of the input period the network spans 9+ locations including Houston, Phoenix, Portland, San Diego, Las Vegas, Albuquerque, Tucson, Denver, and a Sacramento site listed as coming soon.

The platform layers centralized operational features over the embedded site model, including a 48-hour contract and budget response, a single point of contact across studies, simplified site assessments, and what the company describes as accurate enrollment forecasting. Therapeutic breadth is positioned as a differentiator, with active or planned coverage across Pulmonary, Cardiology, Vaccine and Infectious Disease, Endocrinology, Orthopedics, Ophthalmology, Gastroenterology, and Nephrology. Leadership combines a founder-CEO with a National Medical Advisor and Principal Investigator (Dr. Frank LoVecchio, joined August 2024 in Phoenix), and the company cites more than 100 years of combined clinical research experience across its team.

The business model is professional services: revenue is generated through study contracts with pharmaceutical sponsors and CROs, per-patient fees tied to enrollment, and fixed site costs. Go-to-market is structured around three channels — enterprise sales to pharma sponsors and CROs, direct-to-consumer patient recruitment, and a physician partnership program that underpins site embedding and referrals. The company is structured as a US LLC, was founded in 2024, reports 11–50 employees, and has not disclosed outside funding.

Axsendo Clinical Research firmographics

Firmographics
Name
Axsendo Clinical Research
Legal name
Axsendo Clinical Research, LLC
Website
https://www.axsendoclinicalresearch.com
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
11–50 employees
Short description
Axsendo Clinical Research is a woman-owned, multi-site clinical research platform operating 9+ embedded Phase I–IV sites across the western US, serving pharmaceutical sponsors, CROs, and patients through physician-led enrollment partnerships.
Ownership category
akta.pro rank

Where Axsendo Clinical Research is headquartered

Location

Headquarters

HQ city
Phoenix
HQ country
United States
HQ region
North America

Offices9 records

Markets served

Axsendo Clinical Research business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

  1. Clinical Research Services for Sponsors and CROs: Provides Phase I-IV clinical trial site services to pharmaceutical sponsors and Contract Research Organizations. Revenue generated through study contracts, per-patient fees, and fixed-site costs.
  2. Patient Recruitment and Retention Services: Identifies and recruits qualified patients through multiple engagement channels for clinical trials, supporting sponsor enrollment goals.
  3. Participant Compensation: Clinical trial participants may receive compensation for time and travel (e.g., up to $1,500 for low back pain study), which represents a cost offset rather than direct revenue.

Pricing tiers

ModelBillingPrice
OthersMulti-year contractCustom clinical trial site services pricing
OthersPay-as-you-goParticipant compensation for clinical trial participation

Go-to-market motion3 records

Distribution channels3 records

Marketing channels8 records

Axsendo Clinical Research product offering

Product offering

Core offering

Axsendo Clinical Research operates a national site network providing Phase I-IV clinical trial capabilities that integrate research directly into everyday medical care through an embedded site model partnering with local physicians. The company delivers clinical trial site services to pharmaceutical sponsors and CROs across therapeutic areas including pulmonary, cardiology, vaccine and infectious disease, endocrinology, orthopedics, ophthalmology, gastroenterology, and nephrology, while concurrently recruiting patient participants for studies at its 9+ physical research locations.

Product overview

Axsendo Clinical Research operates a unified national site network for clinical trials, offering embedded research services that integrate clinical trials directly into everyday medical care. The platform provides Phase I-IV clinical trial capabilities through multiple locations (Houston, Phoenix, Portland, Sacramento, San Diego, Las Vegas, Albuquerque, Tucson, Denver), partnering with trusted local physicians to expand patient access to innovative therapies. The offering combines experienced research staff, centralized operations, regulatory compliance support, and patient recruitment services across therapeutic focus areas including pulmonary, cardiology, vaccine and infectious disease, endocrinology, orthopedics, ophthalmology, gastroenterology, and nephrology.

Differentiator

Problem solved

Functional benefit

Products and services

  • Clinical Research Site Network Services National site network providing Phase I-IV clinical trial capabilities that connects physician investigators with diverse patient populations to conduct pharmaceutical and medical device studies across multiple therapeutic areas.
  • Clinical Trial Enrollment Services Patient recruitment and enrollment services that identify and connect eligible participants with appropriate clinical studies across multiple therapeutic areas, supporting sponsor enrollment goals.
  • Physician Partnership Program Partnership program offering physicians turn-key research capabilities including experienced clinical research teams, trial pipeline development, patient recruitment, and operational support to integrate clinical research into physician practices without administrative burden.

Quantifiable outcome

  • Lightning-fast 48-hour response to contract and budget inquiries
  • +3 more outcomes

Companies that use Axsendo Clinical Research

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Axsendo Clinical Research technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Axsendo Clinical Research partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Axsendo Clinical Research competitors and assessment

Company assessment

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key highlights7 records

Customer concentration

Axsendo Clinical Research social profiles

Digital presence

Axsendo Clinical Research financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Axsendo Clinical Research leadership team

Management profile

Number of profiles

Profiles2 records

Axsendo Clinical Research funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Axsendo Clinical Research M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Axsendo Clinical Research

What does Axsendo Clinical Research do?

Axsendo Clinical Research operates a national site network providing Phase I-IV clinical trial capabilities that integrate research directly into everyday medical care through an embedded site model partnering with local physicians. The company delivers clinical trial site services to pharmaceutical sponsors and CROs across therapeutic areas including pulmonary, cardiology, vaccine and infectious disease, endocrinology, orthopedics, ophthalmology, gastroenterology, and nephrology, while concurrently recruiting patient participants for studies at its 9+ physical research locations.

Is Axsendo Clinical Research a public or private company?

Axsendo Clinical Research is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Axsendo Clinical Research founded?

Axsendo Clinical Research was founded in 2024. It employs 11 to 50 people.

Where is Axsendo Clinical Research based?

Axsendo Clinical Research is headquartered in Phoenix, United States, in the North America region.

How does Axsendo Clinical Research make money?

Three revenue lines are on record. Clinical Research Services for Sponsors and CROs are the primary driver. The others are patient Recruitment and Retention Services and participant Compensation.

Does Axsendo Clinical Research have an API?

No public API is recorded for Axsendo Clinical Research.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals